FGF7/FGFR2-JunB signalling counteracts the effect of progesterone in luminal breast cancer.
Mol Oncol
; 16(15): 2823-2842, 2022 08.
Article
in En
| MEDLINE
| ID: mdl-35726195
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Transcription Factors
/
Breast Neoplasms
/
Receptor, Fibroblast Growth Factor, Type 2
/
Fibroblast Growth Factor 7
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Mol Oncol
Journal subject:
BIOLOGIA MOLECULAR
/
NEOPLASIAS
Year:
2022
Document type:
Article
Affiliation country:
Polonia
Country of publication:
Estados Unidos